Company: EUDAW
Filing Date: 2025-09-24
Form Type: 20-F/A
Source: 0001493152-25-014808
Chunk: 11

Company: EUDA Health Holdings Ltd
Filing Date: 2025-09-24
Form: 20-F/A
Chunk 11
---
 | $            |     319,158 |   |
| Conversion of debt into a promissory note                                                                           |     | $                   |           - |   |     | $            |           - |   |     | $            |     170,000 |   |
| Conversion of debts into convertible notes                                                                          |     | $                   |           - |   |     | $            |           - |   |     | $            |     206,500 |   |
| Forgiveness of debt by a related party                                                                              |     | $                   |           - |   |     | $            |           - |   |     | $            |   2,763,018 |   |
| Issuance of ordinary shares upon the Reverse Recapitalization                                                       |     | $                   |           - |   |     | $            |           - |   |     | $            |  11,911,459 |   |

<div align='center'>The accompanying notes are an integral part of these consolidated financial statements.</div>

| F-6 |

<div align='center'>EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(In U.S. dollars, unless stated otherwise)</div>

Note 1– Nature of business and organization

EUDA Health Holdings Limited, which until November 17, 2022 was known as 8i Acquisition 2 Corp. (the “Company”, “EUDA” or “8i”) is a company incorporated on January 21, 2021, under the laws of the British Virgin Islands for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Initial Business Combination”). The Company is an “emerging growth company”, as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The Company’s efforts to identify a prospective target business were not limited to a particular industry or geographic location (excluding China). The Articles of Association prohibited the Company from undertaking the Initial Business Combination with any entity that conducts a majority of its business or is headquartered in China (including Hong Kong and Macau).

On November 17, 2022 (the “Closing Date”), EUDA Health Holdings